Navigating technology and regulatory shifts in pharma revenue management. There are many forces at play in the pharmaceutical industry, but company executives believe technological advancements and ...

CoreWeave’s revenue growth slowed from the feverish pace in 2024, but is still benefiting from the artificial intelligence ...

A patient walks into your med spa, excited about their consultation. They love everything about the treatment plan. Then comes the price discussion. In the past, this moment killed countless sales.

Explore Q2 2025 insights for Cooper Companies (COO): 7% organic revenue growth, myopia management gains, cautious forecasts, and long-term optimism.

“However, the data also reveals that profitable practices exist across all revenue bands, suggesting that effective business management can overcome some of the challenges smaller firms face.” Those ...

Management called for $1.06 billion to $1.1 billion in second-quarter revenue. Analysts polled by LSEG had expected $986.7 million. CoreWeave sees $4.9 billion to $5.1 billion in 2025 revenue ...